ALLO
Allogene's Strategic Shift: Accelerating Innovation and Patient-Centricity in Cell Therapy
Allogene, a pioneering biotech company, marked a new chapter in its history with its recent Q2 2026 conference call. Under the leadership of Dr. Zachary Roberts, President and Chief Executive Officer, the company has embarked on a deliberate strategic shift to leverage the unique attributes of allogeneic cell therapy in